The surprising group that will be hit hard by drug pricing reform
By Rachel Cohrs
STAT
Obviously, pharmaceutical companies are upset that they’re going to lose money from Medicare under Democrats’ new drug pricing law. But there’s another, less obvious group that’s concerned as well — long-term care pharmacies that serve almost entirely Medicare patients, and dispense the drugs that will likely enter the price negotiation program first.
While long-term care pharmacies support lowering drug costs, they’re also worried about whether their bottom lines will take a hit as a result, said Alan Rosenbloom, president and CEO of the Senior Care Pharmacy Coalition. They aren’t paid a percentage of the costs for the drugs they dispense, but lower prices will mean smaller pools of discounts for groups like insurers, wholesalers and pharmacies.
“Pharmacies shouldn’t be collateral damage. We didn’t cause high prices,” Rosenbloom said in an interview with STAT.
The two biggest long-term care pharmacy companies are Omnicare, which is owned by CVS Health, and PharMerica, which is owned by private equity firm KKR.
To view the original article click here.
Recent Posts
-
Rep. Beth Van Duyne: Congress can save seniors’ access to medications before it’s too late
Seniors in nursing homes across the country depend on round-the-clock care and medications, perhaps more than any other American patient population. In turn, the nursing homes and assisted living facilities that care for them depend on a small number of specialized long-term care (LTC) pharmacies to ensure their patients have access to the prescription meds they need.
-
Bill Aims to Offset Reimbursement Losses for Long-Term Care Pharmacies Catering to Nursing Homes
Starting in January, falling prices for costly drugs may strain long-term care pharmacies, but proposed legislation backed by advocacy groups aims to subsidize some of this loss. And nursing home advocacy groups are among those urging Congress to pass the Preserving Patient Access to Long-Term Care Pharmacies Act.
-
Drug pricing policy could jeopardize long-term care pharmacies, leaders contend
Senior living and care leaders have joined a coalition calling attention to a policy fix they say would address unintended consequences of Medicare Part D price negotiations that could shutter long-term care pharmacies.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.